Free tool
Cell therapy stocks
We cover 1 company grouped under the Cell therapy theme. The median market value in the group is $21.73M. Across the group, the median move over the past trading day is −12.58%. Price change over the past year runs from −62.9% to −62.9% across the middle 80 percent of the group, with a median of −62.9%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
1 company of 86 matches these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 0NLV.L | FamiCord AG | $21.73M | Micro cap | −62.93% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.